This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Contact Lenses And Solutions Industry

CE-Mark for Medical Devices in Europe II-38

Alternative Technologies to Contact Lenses II-38

Intrastromal Corneal Ring II-38

Radial Keratotomy II-38

Laser Vision Correction II-38

Laser Vision Correction - Key Benefits Ranked in the Order

of Relative Importance to Patients II-38

Photorefractive Keratectomy II-39

LASIK (Laser-Assisted In Situ Keratomileusis) II-39

Research Indicates LASIK to Be Safer Compared to Contact Lenses II-39

Implantable Contact Lenses II-40


Cooper Vision to Re-launch Avaira Toric Contact Lenses II-41

Sauflon Extends Clariti 1 Day Toric Contact Lens Range II-41

Vision-Ease Lens Launches Thindex 1.70 SRC® Coated A SFSV and

SFSV Lenses II-41

Alden Optical Introduces NovaKone Soft Contact Lenses for

Keratoconus II-41

Bausch + Lomb Unveils PureVision2 HD for Astigmatism II-41

CooperVision Introduces Biofinity Multifocal Contact Lenses II-42

Menicon America Rolls out GP Lens Care System II-42

Vistakon Unveils Novel 1-Day Acuvue Moist Brand 90-Pack II-42

Bausch & Lomb Reintroduces ReNu® Fresh™ MPS with New Bottle

Innovation II-42

Target Unveils LensAlert Contact Lens Care Kit II-43

J&J Vision Care to Introduce 1-Day Acuvue Moist Contact Lens II-43

SEED to Introduce Bifocal Disposable Contact Lenses II-43

STMicroelectronics Develops Advanced Contact Lens for Glaucoma

Patients II-43

New Method Discovered to Predict Success of Contact Lensfor

First-time Wearers II-44

Abbott Laboratories Launches RevitaLens II-44



Bausch & Lomb Announces European Launch of ReNu MultiPlus® in

Innovative Bottle II-45

CooperVision Expands Avaira™ Hydrogel Lense Parameters II-45

CooperVision Extends Sphere Powers of Proclear® Toric XR

Contact Lenses II-45

Art Optical Introduces RenovationE Lenses II-46

Clearly Contacts Launches Impressions Colors Private Label

Contact Lenses II-46

Unilens Introduces New Monthly Replacement Toric Multifocal

Contact Lenses II-46

Vistakon to Unveil ACUVUE® OASYS™ Brand Contact Lenses II-47

Vistakon Introduces ACUVUE® DIRECT™ Program II-47

SynergEyes Launches ClearKone™ Contact Lens II-47

Seed to Roll Out 1-Day Contact Lenses II-47

5 of 22

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs